Showing 381 - 400 results of 645 for search '"glaucoma"', query time: 0.06s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384
  5. 385
  6. 386

    Pengaruh Lamanya Pemberian Citicoline dalam Memperbaiki Retinal Nerve Fiber Layer (Rnfl) dan Lapang Pandangan pada Primary Open Angle Glaucoma (Poag) by Kemala Sayuti, Harmen ., Hondrizal .

    Published 2014-01-01
    “…<br />Keywords: Primary Open Angle Glaucoma, Retinal Nerve Fiber Layer, Citicoline</p>…”
    Get full text
    Article
  7. 387
  8. 388
  9. 389
  10. 390
  11. 391
  12. 392

    Size of the Optic Nerve Head and Its Relationship with the Thickness of the Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer in Patients with Primary Open Angle Glaucoma by Nobuko Enomoto, Ayako Anraku, Kyoko Ishida, Asuka Takeyama, Fumihiko Yagi, Goji Tomita

    Published 2015-01-01
    “…To evaluate the relationships among the optic nerve head (ONH) area, macular ganglion cell complex (mGCC) thickness, circumpapillary retinal nerve fiber layer (cpRNFL) thickness, and visual field defects in patients with primary open angle glaucoma (POAG). Methods. This retrospective study included 90 eyes of 90 patients with POAG. …”
    Get full text
    Article
  13. 393

    Safety and Efficacy of Two Trabecular Micro-Bypass Stents as the Sole Procedure in Japanese Patients with Medically Uncontrolled Primary Open-Angle Glaucoma: A Pilot Case Series by Daisuke Shiba, Shingo Hosoda, Saori Yaguchi, Naoki Ozeki, Kenya Yuki, Kazuo Tsubota

    Published 2017-01-01
    “…To evaluate efficacy and safety of a trabecular micro-bypass stent system when used as the sole procedure in Japanese patients with medically uncontrolled primary open-angle glaucoma (POAG). Design. Prospective nonrandomized interventional pilot study. …”
    Get full text
    Article
  14. 394
  15. 395
  16. 396
  17. 397
  18. 398
  19. 399

    Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study by Giulia Coco, Danilo Iannetta, Igino Febbraro, Ester Elmo, Gianluca Manni

    Published 2022-01-01
    “…In this prospective, nonrandomized, open-label pilot study, we evaluated the efficacy of a 0.15% hyaluronic acid (HA) nonpreserved ophthalmic formulation in decreasing DED symptoms in patients with open-angle glaucoma treated with prostaglandin analogs. Methods. 30 patients with DED receiving chronic treatment with prostaglandin analogs for primary open-angle glaucoma or ocular hypertension were administered ophthalmic formulations 3 times daily for 12 weeks. …”
    Get full text
    Article
  20. 400